Prognostic determinants in patients with stage IIIC and IV uterine papillary serous carcinoma

Gynecologic Oncology

Volumn 119, Issue 2, 2010, Pages 299-304

  Rauh Hain, J Alejandro ^a,b   Growdon, Whitfield B ^a   Schorge, John O ^a   Goodman, A K ^a   Boruta, David M ^a   McCann, Christopher ^a   Horowitz, Neil S ^b   Del Carmen, Marcela G ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Optimal cytoreduction; Uterine papillary serous carcinoma

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CYTOREDUCTIVE SURGERY; DATA BASE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PAPILLARY CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; TREATMENT OUTCOME; UTERUS CARCINOMA; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; CARCINOMA, PAPILLARY; CLINICAL TRIAL; CYSTADENOCARCINOMA, SEROUS; DISEASE FREE SURVIVAL; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; SURVIVAL RATE; UTERINE NEOPLASMS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, PAPILLARY; CHEMOTHERAPY, ADJUVANT; CYSTADENOCARCINOMA, SEROUS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; RADIOTHERAPY, ADJUVANT; SURVIVAL RATE; UTERINE NEOPLASMS;

EID: 77957752831     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2010.07.010     Document Type: Article

References (36)

1. A. Jemal, R. Siegel, E. Ward, and Y. Hao Cancer statistics, 2009 CA Cancer J Clin 59 2009 225 249
2. M. Hendrickson, J. Ross, P. Eifel, A. Martinez, and R. Kempson Uterine papillary serous carcinoma: a highly malignant form of endometrial adenocarcinoma Am J Surg Pathol 6 2 1982 93 108
3. J.L. Nicklin, and L.J. Copeland Endometrial papillary serous carcinoma: patterns of spread and treatment Clin Obstet Gynecol 39 3 1996 686 695
4. B.M. Slomovitz, T.W. Burke, P.J. Eifel, L.M. Ramondetta, E.G. Silva, and A. Jhingran Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases Gynecol Oncol 91 3 2003 463 469
5. C. Trope, G.B. Kristensen, and V.M. Abeler Clear-cell and papillary serous cancer: treatment options Best Pract Res 15 3 2001 433 446
6. R.P. Matthews, J. Hutchinson-Colas, M. Maiman, R.G. Fruchter, E.J. Gates, and D. Gibbon Papillary serous and clear cell type lead to poor prognosis of endometrial carcinoma in black women Gynecol Oncol 65 2 1997 206-12.7
7. R.W. Naumann Uterine papillary serous carcinoma: state of the state Curr Oncol Rep 10 6 2008 505 511
8. R.E. Bristow, F. Asrari, E.L. Trimble, and F.J. Montz Extended surgical staging for uterine papillary serous carcinoma: survival outcome of locoregional (stage I-III) disease Gynecol Oncol 81 2 2001 279 286
9. J.K. Chan, V. Loizzi, and M. Youssef Significance of comprehensive surgical staging in noninvasive papillary serous carcinoma of the endometrium Gynecol Oncol 90 2003 181 185
10. R.E. Bristow, R.S. Tomacruz, and D.K. Armstrong Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis J Clin Oncol 20 2002 1248 1259
11. W.T. Creasman Revised FIGO staging for carcinoma of the vulva, cervix and endometrium Int J Gynecol Obstet 105 2009 103 104
12. M. Hendrickson, J. Ross, P. Eifel, A. Martinez, and R. Kempson Uterine papillary serous carcinoma: a highly malignant form of endometrial adenocarcinoma Am J Surg Pathol 6 2 1982 93 108
13. R.E. Bristow, L.R. Duska, and F.J. Montz The role of cytoreductive surgery in the management of stage IV uterine papillary serous carcinoma Gynecol Oncol 81 1 2001 92 99
14. S. Memarzadeh, C.H. Holschneider, R.E. Bristow, N.L. Jones, Y.S. Fu, and B.Y. Karlan FIGO stage III and IV uterine papillary serous carcinoma: impact of residual disease on survival Int J Gynecol Cancer 12 5 2002 454 458
15. K.A. Moller, P.A. Gehrig, L. Van Le, A.A. Secord, and J. Schorge The role of optimal debulking in advanced stage serous carcinoma of the uterus Gynecol Oncol 94 1 2004 170 174
16. M.B. Thomas, A. Mariani, W.A. Cliby, G.L. Keeney, K.C. Podratz, and S.C. Dowdy Role of cytoreduction in stage III and IV uterine papillary serous carcinoma Gynecol Oncol 107 2 2007 190 193
17. J.T. Chambers, S.K. Chambers, E.I. Kohorn, M.L. Carcangiu, and P.E. Schwartz Uterine papillary serous carcinoma treated with intraperitoneal cisplatin and intravenous doxorubicin and cyclophosphamide Gynecol Oncol 60 1996 438 442
18. F.V. Price, S.K. Chambers, M.L. Carcangiu, E.I. Kohorn, P.E. Schwartz, and J.T. Chambers Intravenous cisplatin, doxorubicin, and cyclophosphamide in the treatment of uterine papillary serous carcinoma (UPSC) Gynecol Oncol 51 1993 383 389
19. C. Levenback, T.W. Burke, and E. Silva Uterine papillary serous carcinoma (UPSC) treated with cisplatin, doxorubicin, and cyclophosphamide (PAC) Gynecol Oncol 46 1992 317 321
20. T.D. Le, S.D. Yamada, J.L. Rutgers, and P.J. DiSaia Complete response of a stage IV uterine papillary serous carcinoma to neoadjuvant chemotherapy with taxol and carboplatin Gynecol Oncol 73 1999 461 463
21. L. Ramondetta, T.W. Burke, C. Levenback, M. Bevers, D. Bodurka-Bevers, and D.M. Gershenson Treatment of uterine papillary serous carcinoma with paclitaxel Gynecol Oncol 82 2001 156 161 (Pubitemid 32634969)
22. K.M. Zanotti, J.L. Belinson, A.W. Kennedy, K.D. Webster, and M. Markman The use of paclitaxel and platinum-based chemotherapy in uterine papillary serous carcinoma Gynecol Oncol 74 2 1999 272 277
23. K.M. Zanotti, J.L. Belinson, A.W. Kennedy, K.D. Webster, and M. Markman The use of paclitaxel and platinum-based chemotherapy in uterine papillary serous carcinoma Gynecol Oncol 74 2 1999 272 277
24. A.A. Martinez, S. Weiner, and K. Podratz Improved outcome at 10 years for serous-papillary/clear cell or high-risk endometrial cancer patients treated by adjuvant high-dose whole abdomino-pelvic irradiation Gynecol Oncol 90 2003 537 546
25. P.G. Rose, B.N. Bundy, E.B. Watkins, J.T. Thigpen, G. Deppe, and M.A. Maiman Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer N Engl J Med 340 15 1999 1144 1153
26. H. Pickel, M. Lahousen, E. Petru, H. Stettner, A. Hackl, and K. Kapp Consolidation radiotherapy after carboplatin-based chemotherapy in radically operated advanced ovarian cancer Gynecol Oncol 72 2 1999 215 219
27. P.A. Gehrig, D.E. Morris, and L. Van Le Uterine serous carcinoma: a comparison of therapy for advanced-stage disease Int J Gynecol Cancer 14 3 2004 515 520
28. H. Steed, L. Manchul, B. Rosen, A. Fyles, G. Lockwood, and S. Laframboise Uterine papillary serous carcinoma: evaluation of multimodality treatment with abdominopelvic radiotherapy and chemotherapy Int J Gynecol Cancer 16 Suppl 1 2006 278 285
29. J.S. Low, E.H. Wong, H.S. Tan, S.P. Yap, E.J. Chua, and V.K. Sethi Adjuvant sequential chemotherapy and radiotherapy in uterine papillary serous carcinoma Gynecol Oncol 97 1 2005 171 177
30. A.L. Fields, M.H. Einstein, and A.P. Novetsky Pilot phase II trial of radiation 'sandwiched' between combination paclitaxel/platinum chemotherapy in patients with uterine papillary serous carcinoma (UPSC) Gynecol Oncol 108 2008 201 206
31. A. Alvarez Secord, L.J. Havrilesky, D.M. O'Malley, V. Bae-Jump, and N.D. Fleming A multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial cancer Gynecol Oncol 114 2009 442 447
32. A.D. Santin, S. Bellone, M. Gokden, M. Palmieri, D. Dunn, and J. Agha Overexpression of HER-2/neu in uterine serous papillary cancer Clin Cancer Res 8 2002 1271 1279
33. T.A. Grushko, V.L. Filiaci, A.J. Mundt, K. Ridderstrale, O.I. Olopade, and G.F. Fleming An exploratory analysis of HER-2 amplification and overexpression in advanced endometrial carcinoma: a Gynecologic Oncology Group study Gynecol Oncol 108 2008 3 9
34. J.A. Villella, S. Cohen, D.H. Smith, H. Hibshoosh, and D. Hershman HER-2/neu overexpression in uterine papillary serous cancers and its possible therapeutic implications Int J Gynecol Cancer 16 2006 1897 1902
35. F.E. Odicino, E. Bignotti, E. Rossi, B. Pasinetti, R.A. Tassi, and C. Donzelli HER-2/neu overexpression and amplification in uterine serous papillary carcinoma: comparative analysis of immunohistochemistry, real-time reverse transcription-polymerase chain reaction, and fluorescence in situ hybridization Int J Gynecol Cancer 18 2008 14 21
36. D.M. Boruta II, P.A. Gehrig, A.N. Fader, and A.B. Olawaiye Management of women with uterine papillary serous cancer: a Society of Gynecologic Oncology (SGO) review Gynecol Oncol 115 1 2009 142 153